8 patents
Utility
Gamma Secretase Modulators for the Treatment of Immune System Dysfunction
21 Dec 23
The present invention provides methods of treating an immune system dysfunction or conditions associated with soluble BCMA using gamma secretase modulators or inhibitors in order to both restore immune function and improve the efficacy of therapies directed against BCMA present on the pathogenic B cell.
James Richard BERENSON
Filed: 1 Sep 23
Utility
Anti-cancer Effects of JAK2 Inhibitors In Combination with Thalidomide Derivatives and Glucocorticoids
27 Jul 23
The present invention provides methods of treatment for hematological malignancies involving synergistic combination of a JAK2 inhibitor and a glucocorticoid or a JAK2 inhibitor, thalidomide or thalidomide derivative, and a glucocorticoid.
James R. BERENSON
Filed: 25 Aug 22
Utility
Methods for monitoring immune status of a subject
11 Jul 23
The invention generally provides improved compositions and methods for monitoring immune status of a subject.
James Richard Berenson
Filed: 12 Jan 17
Utility
Diagnostic, prognostic, and monitoring methods for solid tumor cancers
25 Apr 23
The compositions and methods of the invention relate generally to detection of biomarkers for the diagnosis, prognosis, and monitoring of solid tumor cancers.
James Richard Berenson
Filed: 13 Jun 18
Utility
Anti-cancer effects of JAK2 inhibitors in combination with thalidomide derivatives and glucocorticoids
15 Feb 22
The present invention provides methods of treatment for hematological malignancies involving synergistic combination of a JAK2 inhibitor and a glucocorticoid or a JAK2 inhibitor, thalidomide or thalidomide derivative, and a glucocorticoid.
James R. Berenson
Filed: 7 May 19
Utility
Method of Enhancing Immune-based Therapy
6 Jan 22
The present invention provides methods of treating and/or inhibiting cancer by administering a JAK1/2 inhibitor (e.g., ruxolitinib).
James Richard BERENSON, Haiming CHEN
Filed: 31 Oct 19
Utility
Diagnostic, Prognostic, and Monitoring Methods for Solid Tumor Cancers
19 Aug 20
The compositions and methods of the invention relate generally to detection of biomarkers for the diagnosis, prognosis, and monitoring of solid tumor cancers.
James Richard BERENSON
Filed: 12 Jun 18
Utility
Anti-cancer Effects of JAK2 Inhibitors In Combination with Thalidomide Derivatives and Glucocorticoids
29 Jan 20
The present invention provides methods of treatment for hematological malignancies involving synergistic combination of a JAK2 inhibitor and a glucocorticoid or a JAK2 inhibitor, thalidomide or thalidomide derivative, and a glucocorticoid.
James R. BERENSON
Filed: 6 May 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first